Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03243279 · ClinicalTrials.gov registry record
BRS and Outcomes in Cardiothoracic Surgery
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 72
- Enrollment target
NCT03243279: Completed study, sponsored by Duke University.
NCT03243279 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 72 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03243279 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 72 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether baroreceptor sensitivity (the ability of your body to change your heart rate and/or blood pressure in response to a situation) has any effect on how likely you are to suffer certain events after heart or lung surgery. The postoperative events that the investigators will be studying are pain after surgery, atrial fibrillation (an irregular heart rhythm), and cognitive dysfunction (a decline in mental abilities).
Primary Outcome
Non-invasive BRS testing with BIOPAC MP160
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2017-09-15 |
| Est. Completion | 2022-05-31 |
What the finished NCT03243279 record still lists
NCT03243279 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 72 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03243279 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03243279 about?
NCT03243279 is a clinical study titled "BRS and Outcomes in Cardiothoracic Surgery". The purpose of this study is to determine whether baroreceptor sensitivity (the ability of your body to change your heart rate and/or blood pressure in response to a situation) has any effect on how likely you are to suffer certain events after heart or lung surgery. The postoperative events that th...
What is the current status of trial NCT03243279?
This trial is currently completed. The enrollment target is 72 participants. The study started on 2017-09-15. Estimated completion is 2022-05-31.
Who is sponsoring clinical trial NCT03243279?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI